JP2015534990A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015534990A5 JP2015534990A5 JP2015538124A JP2015538124A JP2015534990A5 JP 2015534990 A5 JP2015534990 A5 JP 2015534990A5 JP 2015538124 A JP2015538124 A JP 2015538124A JP 2015538124 A JP2015538124 A JP 2015538124A JP 2015534990 A5 JP2015534990 A5 JP 2015534990A5
- Authority
- JP
- Japan
- Prior art keywords
- aryl
- group
- alkyl
- amino
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261716987P | 2012-10-22 | 2012-10-22 | |
| US61/716,987 | 2012-10-22 | ||
| US201261735458P | 2012-12-10 | 2012-12-10 | |
| US61/735,458 | 2012-12-10 | ||
| PCT/US2013/066041 WO2014066304A1 (en) | 2012-10-22 | 2013-10-22 | Compositions and methods for treating or preventing diseases or disorders associated with misregulated eif4e |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015534990A JP2015534990A (ja) | 2015-12-07 |
| JP2015534990A5 true JP2015534990A5 (enExample) | 2016-12-08 |
Family
ID=50545165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015538124A Pending JP2015534990A (ja) | 2012-10-22 | 2013-10-22 | 誤制御されたｅＩＦ４Ｅに関連する疾患又は障害を治療又は予防するための組成物及び方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9409901B2 (enExample) |
| EP (1) | EP2909203A4 (enExample) |
| JP (1) | JP2015534990A (enExample) |
| AU (1) | AU2013334860B2 (enExample) |
| CA (1) | CA2888889A1 (enExample) |
| IL (1) | IL238415B (enExample) |
| WO (1) | WO2014066304A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2017015456A (es) * | 2015-06-01 | 2018-11-29 | Bantam Pharmaceutical Llc | Compuestos de pirazol y pirrol sustituidos y metodos para su uso por inhibición de iniciación de traducción y tratamiento de enfermedades y trastornos relacionados con ellos. |
| MX2019006296A (es) | 2016-11-30 | 2019-11-12 | Bantam Pharmaceutical Llc | Métodos de uso de compuestos de pirazol y pirazol sustituido y para el tratamiento de enfermedades hiperproliferativas. |
| WO2018102453A1 (en) * | 2016-11-30 | 2018-06-07 | Bantam Pharmaceutical, Llc | Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases |
| US12570975B2 (en) * | 2019-09-03 | 2026-03-10 | Sovargen Co., Ltd. | Composition for diagnosis or treatment of a condition associated with increased activity of EIF4E comprising an EIF4E inhibitor |
| WO2021067752A1 (en) * | 2019-10-04 | 2021-04-08 | Yale University | Targeting cap-dependent translation to reduce seizures in mtor disorders |
| MX2022010944A (es) * | 2020-03-03 | 2022-11-09 | Pic Therapeutics Inc | Inhibidores del factor de iniciacion de traduccion eucariotica 4e (eif4e) y sus usos. |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5472954A (en) | 1992-07-14 | 1995-12-05 | Cyclops H.F. | Cyclodextrin complexation |
| US5324718A (en) | 1992-07-14 | 1994-06-28 | Thorsteinn Loftsson | Cyclodextrin/drug complexation |
| MXPA06012130A (es) * | 2004-04-20 | 2007-01-31 | Transtech Pharma Inc | Derivados de tiazol y pirimidina substituidos como moduladores del receptor de melanocortina. |
| US8257931B2 (en) * | 2005-01-21 | 2012-09-04 | President And Fellows Of Harvard College | Regulation of protein synthesis |
| GB0614068D0 (en) | 2006-07-14 | 2006-08-23 | Glaxo Group Ltd | Compounds |
| GB0614070D0 (en) * | 2006-07-14 | 2006-08-23 | Glaxo Group Ltd | Compounds |
| AR063531A1 (es) * | 2006-10-31 | 2009-01-28 | Schering Corp | Derivados de anilinopiperazina y composicion farmaceutica |
| RU2010106878A (ru) * | 2007-07-31 | 2011-09-10 | Шеринг Корпорейшн (US) | Комбинация антимитотического агента и ингибитора аврора киназы как средство для лечения рака |
| WO2012006068A2 (en) * | 2010-06-28 | 2012-01-12 | President And Fellows Of Harvard College | Compounds for the inhibition of cellular proliferation |
-
2013
- 2013-10-22 CA CA2888889A patent/CA2888889A1/en not_active Abandoned
- 2013-10-22 EP EP13849178.2A patent/EP2909203A4/en not_active Withdrawn
- 2013-10-22 JP JP2015538124A patent/JP2015534990A/ja active Pending
- 2013-10-22 US US14/437,251 patent/US9409901B2/en not_active Expired - Fee Related
- 2013-10-22 AU AU2013334860A patent/AU2013334860B2/en not_active Ceased
- 2013-10-22 WO PCT/US2013/066041 patent/WO2014066304A1/en not_active Ceased
-
2015
- 2015-04-21 IL IL238415A patent/IL238415B/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016528301A5 (enExample) | ||
| EA025086B9 (ru) | Производные индоламида и родственные соединения для использования при лечении нейродегенеративных заболеваний | |
| NZ708593A (en) | Novel pyrazole derivative | |
| UA109698C2 (xx) | Похідні азаіндазолу або діазаіндазолу як медикамент | |
| EA201391486A1 (ru) | Способы и композиции для лечения болезни паркинсона | |
| BR112015029512A2 (pt) | derivados de pirazolopirrolidina e seu uso no tratamento de doenças | |
| PH12014500472A1 (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| PH12014502218A1 (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| EP4227304A3 (en) | Thiadiazole analogs and their use for treating diseases associated with a deficiency of smn motor neurons | |
| EP4663636A3 (en) | Trifluoromethyl substituted pyrazoles as human plasma kallikrein inhibitors | |
| WO2014144130A3 (en) | Pharmaceutical composition comprising an ampk activator and a serotonergic agent and methods of use thereof | |
| EP4275748A3 (en) | Compositions and methods for treating cns disorders | |
| UA109991C2 (xx) | Карбаматні сполуки, їх отримання і застосування | |
| EA201391485A1 (ru) | Способы и композиции для лечения нейродегенеративных заболеваний | |
| MX2015012435A (es) | Derivados de 3-fenilpropilamina sustituidos para el tratamiento de enfermedades y trastornos oftalmicos. | |
| PH12017502049A1 (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| WO2011127333A3 (en) | Compounds for treating disease, for administering, and for pharmaceutical compositions | |
| HK1198619A1 (en) | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| JP2014513136A5 (enExample) | ||
| ECSP20030074A (es) | Nuevos profármacos de catecolamina para uso en el tratamiento de la enfermedad de parkinson | |
| IN2014DN05869A (enExample) | ||
| IN2014DN08582A (enExample) | ||
| EA201891931A1 (ru) | Новые ингибиторы фосфатидилинозитол-3-киназы гамма | |
| SG10201810404XA (en) | Combination comprising a glucocorticoid and edo-s101 | |
| WO2015047982A3 (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |